True Health Medical has launched HK IPO consisting of 3.6M H shares at HK$119.30–135.40 per share to fund R&D activities and commercialization of the Core Product. Subscription will close on June 25.
What is covered in the Full Insight:
Introduction and IPO Details
Company Background and Market Position
Product Portfolio and Commercialization Strategies